在膀胱癌治疗，要获得43%CR（完全缓解）是非常不容易的

At 12 months more than 75% of patients treated with Vicinium were estimated to remain cystectomy-free at 3 years, 90% were estimated to remain progression-free for 2 years or more and 29% were estimated to remain event free at 1 year.

The FDA had granted a fast track designation to Vicinium last August for the treatment of patients with BCG-unresponsive, high-grade NMIBC. References

所有跟帖： 

• 非常有效和安全的治疗膀胱癌药物。而且，以后，这个药物还可以用于其它实体瘤。前程远大 -Eric999- ♂ (1221 bytes) () 09/18/2020 postreply 09:42:53

• 2020.6: Phase 3 Results Of Vicinium In BCG-Unresponsive Non-Musc -Eric999- ♂ (4399 bytes) () 09/18/2020 postreply 09:50:27